Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes

scientific article

Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1476-5381.2011.01375.X
P932PMC publication ID3174419
P698PubMed publication ID21449976
P5875ResearchGate publication ID50935524

P50authorDitte C. AndersenQ42830801
Pia JeppesenQ46159805
Jakob Lerche HansenQ54992089
Anne Yael NossentQ55098202
P2093author name stringSteen Gammeltoft
Mikael Schneider
Tilde Eskildsen
Gitte Lund Christensen
Søren Paludan Sheikh
Hasse Brønnum Jensen
P2860cites workSide-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.Q43922018
Arrestins block G protein-coupled receptor-mediated apoptosisQ44820320
Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential.Q45139526
Identification of functional angiotensin II receptors on rat cardiac fibroblastsQ46184530
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cellsQ46662936
The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused heartsQ53021334
Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytesQ53558215
Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.Q54792697
Guide to Receptors and Channels (GRAC), 4th EditionQ56639335
AT1 receptor Gαq protein-independent signalling transcriptionally activates only a few genes directly, but robustly potentiates gene regulation from the β2-adrenergic receptorQ63208651
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytesQ71601468
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophyQ71620642
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in miceQ73030690
Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and FibroblastsQ73661346
Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptorsQ73841698
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognitionQ74662431
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxisQ24337549
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesQ24534395
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesisQ24537628
MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesisQ24634064
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophyQ28281648
Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosaQ28569428
{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD PhosphorylationQ28577649
An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivoQ28578913
Control of stress-dependent cardiac growth and gene expression by a microRNAQ28587851
MicroRNA-133 controls cardiac hypertrophyQ29616572
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR dataQ29616810
Gene regulatory networks in the evolution and development of the heartQ29619086
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failureQ29619548
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisQ29619873
Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonistsQ34122067
Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptorQ34548751
Microtranscriptome regulation by gonadotropin-releasing hormoneQ34974789
Cell-cell contact globally activates microRNA biogenesis.Q34975000
Regulatory circuit of human microRNA biogenesisQ35753722
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular systemQ36548154
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptorQ37432858
Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networksQ37448085
Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcriptionQ38296408
Beta-arrestin-mediated signaling regulates protein synthesis.Q39782848
Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cellsQ39856113
Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation.Q39863122
A novel Galphaq/11-selective inhibitorQ40520558
Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling stateQ42482690
Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic responseQ42789926
MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes.Q42827656
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmicroRNAQ310899
P304page(s)394-404
P577publication date2011-09-01
P1433published inBritish Journal of PharmacologyQ919631
P1476titleAngiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes
P478volume164

Reverse relations

cites work (P2860)
Q44307084Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts
Q37007126Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans
Q46949305Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts
Q90171814Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway
Q88956304Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis
Q35251097Cardiac Insulin Resistance and MicroRNA Modulators
Q35558398Heterotrimeric G protein-mediated signaling and its non-canonical regulation in the heart
Q90478773Interactions Among Non-Coding RNAs in Diabetic Nephropathy
Q33112080Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells.
Q87448990MicroRNA as a novel component of the tissue renin angiotensin system
Q37419073MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.
Q38133419MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.
Q44145967Pharmacogenomics of antihypertensive drug response: new evidence of miRNA controlling blood pressure
Q38190443Regulatory RNAs and paracrine networks in the heart.
Q38833827Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy
Q39006068Role of MicroRNA in Endothelial Dysfunction and Hypertension
Q64924544Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.
Q35625794Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
Q92337905Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway
Q64254485Tetrahydroxy stilbene glucoside alleviates palmitic acid-induced inflammation and apoptosis in cardiomyocytes by regulating miR-129-3p/Smad3 signaling
Q35178127The ACE2/Apelin Signaling, MicroRNAs, and Hypertension
Q51024991The association of circulating miR-30a, miR-29 and miR-133 with white-coat hypertension
Q35786347The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Q45097264The microRNA-132/212 family fine-tunes multiple targets in Angiotensin II signalling in cardiac fibroblasts
Q37204328miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy